Stemlife Berhad is a majority-owned subsidiary of Singapore Exchange mainboard-listed Cordlife Group Limited (“Cordlife” or the “Group”). The Group owns the largest network of stem cell banks in Asia with facilities in six countries and marketing presence in four other countries. Since its founding in 2001, Cordlife has helped more than 500,000 parents store their babies’ cord blood and cord tissue. Also established in 2001, Stemlife is one of the only two stem cell banks in Malaysia that is accredited by AABB (formerly known as American Association of Blood Banks). AABB is the de facto international quality yardstick in the industry and most transplant physicians around the world trust that cord blood handled by AABB accredited banks are properly collected, tested, processed and stored in a way that is consistent with enhancing the chances of a successful transplant.